Literature DB >> 22172357

Watchful waiting for severe mitral regurgitation.

Raphael Rosenhek1.   

Abstract

Watchful waiting is an established treatment strategy for asymptomatic patients with severe organic mitral regurgitation. It is based on indications for surgery that are based on current European Society of Cardiology and American Heart Association/American College of Cardiology guideline recommendations, which are defined by symptom onset, impairment of left ventricular function, and left ventricular enlargement. Excellent outcome is achieved when patients are periodically followed with clinical and echocardiographic examinations and when surgery is performed in expert centers. The strategy is based on the recognition of mitral regurgitation at an early symptomatic stage, avoiding a delayed referral of these patients. There is an ongoing debate about whether surgery should be performed in asymptomatic patients with preserved ventricular function. Ultimately, decision-making needs to be individualized and to take individual patient-related factors and local resources (including the natural history of the disease, the risk of surgery, and the likelihood of successful mitral valve repair) into consideration to obtain an optimal outcome with medical and surgical management.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22172357     DOI: 10.1053/j.semtcvs.2011.09.002

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  6 in total

1.  How has robotic repair changed the landscape of mitral valve surgery?

Authors:  Amit K Taggarse; Rakesh M Suri; Richard C Daly
Journal:  Ann Cardiothorac Surg       Date:  2015-07

Review 2.  Early surgical intervention or watchful waiting for the management of asymptomatic mitral regurgitation: a systematic review and meta-analysis.

Authors:  Andrew B Goldstone; William L Patrick; Jeffrey E Cohen; Chiaka N Aribeana; Rita Popat; Y Joseph Woo
Journal:  Ann Cardiothorac Surg       Date:  2015-05

3.  Impact of duration of mitral regurgitation on outcomes in asymptomatic patients with myxomatous mitral valve undergoing exercise stress echocardiography.

Authors:  Peyman Naji; Fadi Asfahan; Tyler Barr; L Leonardo Rodriguez; Richard A Grimm; Shikhar Agarwal; James D Thomas; A Marc Gillinov; Tomislav Mihaljevic; Brian P Griffin; Milind Y Desai
Journal:  J Am Heart Assoc       Date:  2015-02-11       Impact factor: 5.501

4.  Importance of exercise capacity in predicting outcomes and determining optimal timing of surgery in significant primary mitral regurgitation.

Authors:  Peyman Naji; Brian P Griffin; Tyler Barr; Fadi Asfahan; A Marc Gillinov; Richard A Grimm; L Leonardo Rodriguez; Tomislav Mihaljevic; William J Stewart; Milind Y Desai
Journal:  J Am Heart Assoc       Date:  2014-09-11       Impact factor: 5.501

5.  Long-Term Results of Mitral Valve Repair.

Authors:  Francisco Diniz Affonso da Costa; Daniele de Fátima Fornazari Colatusso; Gustavo Luis do Santos Martin; Kallyne Carolina Silva Parra; Mariana Cozer Botta; Eduardo Mendel Balbi Filho; Myrian Veloso; Gabriela Miotto; Andreia Dumsch de Aragon Ferreira; Claudinei Colatusso
Journal:  Braz J Cardiovasc Surg       Date:  2018 Jan-Feb

6.  Forward Left Ventricular Ejection Fraction: A Simple Risk Marker in Patients With Primary Mitral Regurgitation.

Authors:  Marlène Dupuis; Haïfa Mahjoub; Marie-Annick Clavel; Nancy Côté; Oumhani Toubal; Lionel Tastet; Jean G Dumesnil; Kim O'Connor; Abdellaziz Dahou; Christophe Thébault; Catherine Bélanger; Jonathan Beaudoin; Marie Arsenault; Mathieu Bernier; Philippe Pibarot
Journal:  J Am Heart Assoc       Date:  2017-10-27       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.